NCT00503412 Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors Status COMPLETED Phase PHASE1
NCT00503204 Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour Status COMPLETED Phase PHASE1
NCT00503061 A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART Status COMPLETED Phase N/A
NCT00502567 A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00502385 Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML Status COMPLETED Phase PHASE1
NCT00502164 Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer Status COMPLETED Phase PHASE1
NCT00502060 Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00501605 Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases Status COMPLETED Phase PHASE1
NCT00501111 Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00500370 A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients Status COMPLETED Phase PHASE2
NCT00500318 A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT00498628 Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency Status COMPLETED Phase PHASE2
NCT00497991 Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT00497731 AZD1152 in Patients With Advanced Solid Malignancies-Study 1 Status TERMINATED Phase PHASE1
NCT00497679 AZD1152 in Patients With Advanced Solid Malignancies-Study 3 Status TERMINATED Phase PHASE1
NCT00497458 Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects Status UNKNOWN Phase PHASE2
NCT00496665 ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00496470 Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD. Status COMPLETED Phase PHASE4
NCT00494442 Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer Status COMPLETED Phase PHASE2